Ligand validation:4TTA

FMC: (1S)-1-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-D-ribitol

FMC is a Ligand Of Interest in 4TTA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TTA_FMC_D_302	29%	21%	0.183	0.843	1.33	1.93	2	4	0	0	100%	0.67
4TTA_FMC_C_301	19%	23%	0.216	0.813	1.27	1.9	2	4	2	0	100%	0.67
3UT6_FMC_C_300	93%	23%	0.078	0.971	1.3	1.87	3	5	2	0	100%	1
4TS9_FMC_A_300	71%	22%	0.121	0.943	1.31	1.94	1	4	0	0	100%	0.77
4TTJ_FMC_A_302	31%	4%	0.2	0.866	3.25	2.38	7	3	0	0	100%	0.65
4TTI_FMC_D_302	30%	19%	0.19	0.855	1.37	2.07	2	3	0	0	100%	0.59
6XZ2_FMC_B_301	25%	5%	0.152	0.784	1.33	4.07	4	6	0	0	100%	0.708
3NM5_FMC_A_501	92%	23%	0.074	0.964	1.31	1.85	2	3	0	0	100%	1
3BL6_FMC_A_229	83%	18%	0.093	0.952	1.81	1.74	4	7	2	0	100%	1
6F4X_FMC_B_301	82%	4%	0.08	0.934	1.46	4.1	4	5	0	0	100%	1
1SD1_FMC_A_1330	81%	17%	0.102	0.954	1.96	1.65	5	2	0	0	100%	1
1NC3_FMC_A_233	78%	14%	0.117	0.961	1.89	1.97	3	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.